Treatment of relapsed AML and MDS after allogeneic stem cell transplantation with decitabine and DLI—a retrospective multicenter analysis on behalf ... View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2017-11-18

AUTHORS

Thomas Schroeder, Christina Rautenberg, William Krüger, Uwe Platzbecker, Gesine Bug, Juliane Steinmann, Stefan Klein, Olaf Hopfer, Kathrin Nachtkamp, Mustafa Kondakci, Stefanie Geyh, Rainer Haas, Ulrich Germing, Martin Bornhäuser, Guido Kobbe

ABSTRACT

In contrast to the evidence regarding azacitidine (Aza), there is limited knowledge about the combination of decitabine (DAC) and donor lymphocyte infusions as salvage therapy for relapse after allogeneic stem cell transplantation (allo-SCT) so far. We retrospectively analyzed data of 36 patients with hematological (n = 35) or molecular relapse (n = 1) of acute myeloid leukemia (AML, n = 29) or myelodysplastic syndrome (MDS, n = 7) collected from 6 German transplant centers. Patients were treated with a median of 2 cycles DAC (range, 1 to 11). DAC was the first salvage therapy in 16 patients (44%), whereas 20 patients (56%) had previously received 1 to 5 lines of salvage therapy including 16 of them had been treated with Aza. In 22 patients (61%), a median of 2 DLI per patient (range, 1 to 5) was administered in addition to DAC. As a result, overall response rate was 25% including 6 complete remissions (CR, 17%) and 3 partial remissions (PR, 8%). Three patients within the first-line group achieved CR, while also 3 patients receiving DAC as second-line treatment reached CR including 2 patients with previous Aza failure. Median duration of CR was 10 months (range, 2 to 33) and no patient relapsed so far. The 2-year OS rate was 11% (± 6%) without any difference between first-line and pretreated patients. Incidence of acute and chronic graft-versus-host disease was 19 and 5%. Taken together, DAC exerts clinical efficacy in patients with AML or MDS relapsing after allo-SCT and is able to induce durable remissions in individual patients suggesting that DAC may be an alternative to Aza or even a second choice after Aza failure. More... »

PAGES

335-342

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00277-017-3185-5

DOI

http://dx.doi.org/10.1007/s00277-017-3185-5

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1092764909

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/29151133


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antimetabolites, Antineoplastic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Azacitidine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Decitabine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Graft vs Host Disease", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hematopoietic Stem Cell Transplantation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Leukemia, Myeloid, Acute", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lymphocyte Transfusion", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Myelodysplastic Syndromes", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Recurrence", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Remission Induction", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Salvage Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Survival Analysis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Transplantation, Homologous", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Hematology, Oncology and Clinical Immunology, Medical Faculty, University of Duesseldorf, Moorenstr. 5, 40225, D\u00fcsseldorf, Germany", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Hematology, Oncology and Clinical Immunology, Medical Faculty, University of Duesseldorf, Moorenstr. 5, 40225, D\u00fcsseldorf, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Schroeder", 
        "givenName": "Thomas", 
        "id": "sg:person.01271136615.68", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01271136615.68"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hematology, Oncology and Clinical Immunology, Medical Faculty, University of Duesseldorf, Moorenstr. 5, 40225, D\u00fcsseldorf, Germany", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Hematology, Oncology and Clinical Immunology, Medical Faculty, University of Duesseldorf, Moorenstr. 5, 40225, D\u00fcsseldorf, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rautenberg", 
        "givenName": "Christina", 
        "id": "sg:person.014702750321.08", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014702750321.08"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Clinic and Policlinic for Internal Medicine C, Hematology and Oncology, University of Greifswald, Greifswald, Germany", 
          "id": "http://www.grid.ac/institutes/grid.5603.0", 
          "name": [
            "Clinic and Policlinic for Internal Medicine C, Hematology and Oncology, University of Greifswald, Greifswald, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kr\u00fcger", 
        "givenName": "William", 
        "id": "sg:person.01121306556.02", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01121306556.02"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Medical Clinic and Policlinic I, University Hospital Carl Gustav Carus, Dresden, Germany", 
          "id": "http://www.grid.ac/institutes/grid.412282.f", 
          "name": [
            "Medical Clinic and Policlinic I, University Hospital Carl Gustav Carus, Dresden, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Platzbecker", 
        "givenName": "Uwe", 
        "id": "sg:person.0670313557.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0670313557.25"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medicine II, University Hospital Frankfurt, Frankfurt am Main, Germany", 
          "id": "http://www.grid.ac/institutes/grid.411088.4", 
          "name": [
            "Department of Medicine II, University Hospital Frankfurt, Frankfurt am Main, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bug", 
        "givenName": "Gesine", 
        "id": "sg:person.0660354231.27", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0660354231.27"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medicine II, University Hospital Frankfurt, Frankfurt am Main, Germany", 
          "id": "http://www.grid.ac/institutes/grid.411088.4", 
          "name": [
            "Department of Medicine II, University Hospital Frankfurt, Frankfurt am Main, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Steinmann", 
        "givenName": "Juliane", 
        "id": "sg:person.016431005447.39", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016431005447.39"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Med. Clinic III, University Medicine Mannheim, Mannheim, Germany", 
          "id": "http://www.grid.ac/institutes/grid.411778.c", 
          "name": [
            "Med. Clinic III, University Medicine Mannheim, Mannheim, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Klein", 
        "givenName": "Stefan", 
        "id": "sg:person.01007205467.33", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01007205467.33"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Klinikum Frankfurt (Oder) GmbH, Med. Clinic I, Frankfurt (Oder), Frankfurt, Germany", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Klinikum Frankfurt (Oder) GmbH, Med. Clinic I, Frankfurt (Oder), Frankfurt, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hopfer", 
        "givenName": "Olaf", 
        "id": "sg:person.01200517504.74", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01200517504.74"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hematology, Oncology and Clinical Immunology, Medical Faculty, University of Duesseldorf, Moorenstr. 5, 40225, D\u00fcsseldorf, Germany", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Hematology, Oncology and Clinical Immunology, Medical Faculty, University of Duesseldorf, Moorenstr. 5, 40225, D\u00fcsseldorf, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nachtkamp", 
        "givenName": "Kathrin", 
        "id": "sg:person.01367010764.53", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01367010764.53"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hematology, Oncology and Clinical Immunology, Medical Faculty, University of Duesseldorf, Moorenstr. 5, 40225, D\u00fcsseldorf, Germany", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Hematology, Oncology and Clinical Immunology, Medical Faculty, University of Duesseldorf, Moorenstr. 5, 40225, D\u00fcsseldorf, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kondakci", 
        "givenName": "Mustafa", 
        "id": "sg:person.01150516001.45", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01150516001.45"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hematology, Oncology and Clinical Immunology, Medical Faculty, University of Duesseldorf, Moorenstr. 5, 40225, D\u00fcsseldorf, Germany", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Hematology, Oncology and Clinical Immunology, Medical Faculty, University of Duesseldorf, Moorenstr. 5, 40225, D\u00fcsseldorf, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Geyh", 
        "givenName": "Stefanie", 
        "id": "sg:person.0766505315.56", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0766505315.56"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hematology, Oncology and Clinical Immunology, Medical Faculty, University of Duesseldorf, Moorenstr. 5, 40225, D\u00fcsseldorf, Germany", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Hematology, Oncology and Clinical Immunology, Medical Faculty, University of Duesseldorf, Moorenstr. 5, 40225, D\u00fcsseldorf, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Haas", 
        "givenName": "Rainer", 
        "id": "sg:person.01127414674.14", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01127414674.14"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hematology, Oncology and Clinical Immunology, Medical Faculty, University of Duesseldorf, Moorenstr. 5, 40225, D\u00fcsseldorf, Germany", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Hematology, Oncology and Clinical Immunology, Medical Faculty, University of Duesseldorf, Moorenstr. 5, 40225, D\u00fcsseldorf, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Germing", 
        "givenName": "Ulrich", 
        "id": "sg:person.01362464041.20", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01362464041.20"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Medical Clinic and Policlinic I, University Hospital Carl Gustav Carus, Dresden, Germany", 
          "id": "http://www.grid.ac/institutes/grid.412282.f", 
          "name": [
            "Medical Clinic and Policlinic I, University Hospital Carl Gustav Carus, Dresden, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bornh\u00e4user", 
        "givenName": "Martin", 
        "id": "sg:person.01036310055.41", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01036310055.41"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hematology, Oncology and Clinical Immunology, Medical Faculty, University of Duesseldorf, Moorenstr. 5, 40225, D\u00fcsseldorf, Germany", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Hematology, Oncology and Clinical Immunology, Medical Faculty, University of Duesseldorf, Moorenstr. 5, 40225, D\u00fcsseldorf, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kobbe", 
        "givenName": "Guido", 
        "id": "sg:person.01164073234.53", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01164073234.53"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s00277-012-1607-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021337269", 
          "https://doi.org/10.1007/s00277-012-1607-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bmt.2009.266", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026051000", 
          "https://doi.org/10.1038/bmt.2009.266"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bmt.2013.233", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048090912", 
          "https://doi.org/10.1038/bmt.2013.233"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/leu.2013.64", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051101519", 
          "https://doi.org/10.1038/leu.2013.64"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bmt.2009.222", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042146563", 
          "https://doi.org/10.1038/bmt.2009.222"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/leu.2013.7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019069739", 
          "https://doi.org/10.1038/leu.2013.7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/leu.2011.234", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037902470", 
          "https://doi.org/10.1038/leu.2011.234"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bmt.2015.10", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034490318", 
          "https://doi.org/10.1038/bmt.2015.10"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2017-11-18", 
    "datePublishedReg": "2017-11-18", 
    "description": "In contrast to the evidence regarding azacitidine (Aza), there is limited knowledge about the combination of decitabine (DAC) and donor lymphocyte infusions as salvage therapy for relapse after allogeneic stem cell transplantation (allo-SCT) so far. We retrospectively analyzed data of 36 patients with hematological (n\u2009=\u200935) or molecular relapse (n\u2009=\u20091) of acute myeloid leukemia (AML, n\u2009=\u200929) or myelodysplastic syndrome (MDS, n\u2009=\u20097) collected from 6 German transplant centers. Patients were treated with a median of 2 cycles DAC (range, 1 to 11). DAC was the first salvage therapy in 16 patients (44%), whereas 20 patients (56%) had previously received 1 to 5 lines of salvage therapy including 16 of them had been treated with Aza. In 22 patients (61%), a median of 2\u00a0DLI per patient (range, 1 to 5) was administered in addition to DAC. As a result, overall response rate was 25% including 6 complete remissions (CR, 17%) and 3 partial remissions (PR, 8%). Three patients within the first-line group achieved CR, while also 3 patients receiving DAC as second-line treatment reached CR including 2 patients with previous Aza failure. Median duration of CR was 10\u00a0months (range, 2 to 33) and no patient relapsed so far. The 2-year OS rate was 11% (\u00b1\u20096%) without any difference between first-line and pretreated patients. Incidence of acute and chronic graft-versus-host disease was 19 and 5%. Taken together, DAC exerts clinical efficacy in patients with AML or MDS relapsing after allo-SCT and is able to induce durable remissions in individual patients suggesting that DAC may be an alternative to Aza or even a second choice after Aza failure.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s00277-017-3185-5", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1358129", 
        "issn": [
          "0939-5555", 
          "1432-0584"
        ], 
        "name": "Annals of Hematology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "97"
      }
    ], 
    "keywords": [
      "allogeneic stem cell transplantation", 
      "stem cell transplantation", 
      "salvage therapy", 
      "cell transplantation", 
      "first salvage therapy", 
      "first-line group", 
      "donor lymphocyte infusion", 
      "second-line treatment", 
      "retrospective multicenter analysis", 
      "German transplant centers", 
      "overall response rate", 
      "acute myeloid leukemia", 
      "combination of decitabine", 
      "molecular relapse", 
      "chronic graft", 
      "lymphocyte infusion", 
      "complete remission", 
      "partial remission", 
      "host disease", 
      "allo-SCT", 
      "durable remissions", 
      "median duration", 
      "transplant centers", 
      "OS rates", 
      "multicenter analysis", 
      "myelodysplastic syndrome", 
      "clinical efficacy", 
      "myeloid leukemia", 
      "individual patients", 
      "study group", 
      "patients", 
      "response rate", 
      "remission", 
      "therapy", 
      "relapse", 
      "transplantation", 
      "AML", 
      "decitabine", 
      "median", 
      "treatment", 
      "second choice", 
      "relapsing", 
      "DLI", 
      "limited knowledge", 
      "failure", 
      "group", 
      "infusion", 
      "syndrome", 
      "graft", 
      "leukemia", 
      "incidence", 
      "disease", 
      "months", 
      "efficacy", 
      "duration", 
      "rate", 
      "AZA", 
      "MDS", 
      "evidence", 
      "differences", 
      "center", 
      "contrast", 
      "combination", 
      "data", 
      "addition", 
      "lines", 
      "knowledge", 
      "alternative", 
      "choice", 
      "analysis", 
      "results", 
      "Cr", 
      "behalf", 
      "DAC"
    ], 
    "name": "Treatment of relapsed AML and MDS after allogeneic stem cell transplantation with decitabine and DLI\u2014a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group", 
    "pagination": "335-342", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1092764909"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00277-017-3185-5"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "29151133"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00277-017-3185-5", 
      "https://app.dimensions.ai/details/publication/pub.1092764909"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-08-04T17:05", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220804/entities/gbq_results/article/article_754.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s00277-017-3185-5"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00277-017-3185-5'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00277-017-3185-5'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00277-017-3185-5'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00277-017-3185-5'


 

This table displays all metadata directly associated to this object as RDF triples.

363 TRIPLES      21 PREDICATES      128 URIs      112 LITERALS      28 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00277-017-3185-5 schema:about N0f7981716dc8407b87519864fe107a47
2 N4f6649d94f5445d4a0c8364f5275b361
3 N617f8b0c582842daa045e97e144f1153
4 N679dc90214034ca88f35b925f8bf5a7b
5 N6e1d7328a75f4f959ba359420d518e6d
6 N778e6b63cbdd499d98bd2be7d8419237
7 N8093015258c549d6903167d972f76a85
8 N828b9825985a4f068d7bb7f456fcbcfc
9 N8b97b9e1874c4322bc475c7ac4dfe0f5
10 Naad72d3432c546d59c207e9fa0d112ca
11 Naaf8350563bb43ca87f3301cbb79b061
12 Nb309da5affc440378f21cfc550396691
13 Nbb809e4e496746eeb124cbda2cc1ff6d
14 Nc605934229a9432ebea2a9feb33b5917
15 Ncae05d567e5246738d1f0c655c67f9d6
16 Ncef7ef0d28b8473d876a1c5136bfb751
17 Nd54542c355f849a0b95c0f1458a2feb5
18 Ndd8c351aab8e4d488bec8ffd518271fe
19 Ndffcccf166464f2ea0bcf7bee6ba718d
20 Ne98a1478f6b44cd58fcf22c2aae235f0
21 Nf9ad27ec409f43e286cc5086aa96be20
22 anzsrc-for:11
23 anzsrc-for:1102
24 schema:author N3b33f19a81f6453eb18a3425c7ef7207
25 schema:citation sg:pub.10.1007/s00277-012-1607-y
26 sg:pub.10.1038/bmt.2009.222
27 sg:pub.10.1038/bmt.2009.266
28 sg:pub.10.1038/bmt.2013.233
29 sg:pub.10.1038/bmt.2015.10
30 sg:pub.10.1038/leu.2011.234
31 sg:pub.10.1038/leu.2013.64
32 sg:pub.10.1038/leu.2013.7
33 schema:datePublished 2017-11-18
34 schema:datePublishedReg 2017-11-18
35 schema:description In contrast to the evidence regarding azacitidine (Aza), there is limited knowledge about the combination of decitabine (DAC) and donor lymphocyte infusions as salvage therapy for relapse after allogeneic stem cell transplantation (allo-SCT) so far. We retrospectively analyzed data of 36 patients with hematological (n = 35) or molecular relapse (n = 1) of acute myeloid leukemia (AML, n = 29) or myelodysplastic syndrome (MDS, n = 7) collected from 6 German transplant centers. Patients were treated with a median of 2 cycles DAC (range, 1 to 11). DAC was the first salvage therapy in 16 patients (44%), whereas 20 patients (56%) had previously received 1 to 5 lines of salvage therapy including 16 of them had been treated with Aza. In 22 patients (61%), a median of 2 DLI per patient (range, 1 to 5) was administered in addition to DAC. As a result, overall response rate was 25% including 6 complete remissions (CR, 17%) and 3 partial remissions (PR, 8%). Three patients within the first-line group achieved CR, while also 3 patients receiving DAC as second-line treatment reached CR including 2 patients with previous Aza failure. Median duration of CR was 10 months (range, 2 to 33) and no patient relapsed so far. The 2-year OS rate was 11% (± 6%) without any difference between first-line and pretreated patients. Incidence of acute and chronic graft-versus-host disease was 19 and 5%. Taken together, DAC exerts clinical efficacy in patients with AML or MDS relapsing after allo-SCT and is able to induce durable remissions in individual patients suggesting that DAC may be an alternative to Aza or even a second choice after Aza failure.
36 schema:genre article
37 schema:isAccessibleForFree false
38 schema:isPartOf Nab7f64703be141a581bb5f31d7b50b69
39 Nb1737913499c4b32ab05d24b948e3b52
40 sg:journal.1358129
41 schema:keywords AML
42 AZA
43 Cr
44 DAC
45 DLI
46 German transplant centers
47 MDS
48 OS rates
49 acute myeloid leukemia
50 addition
51 allo-SCT
52 allogeneic stem cell transplantation
53 alternative
54 analysis
55 behalf
56 cell transplantation
57 center
58 choice
59 chronic graft
60 clinical efficacy
61 combination
62 combination of decitabine
63 complete remission
64 contrast
65 data
66 decitabine
67 differences
68 disease
69 donor lymphocyte infusion
70 durable remissions
71 duration
72 efficacy
73 evidence
74 failure
75 first salvage therapy
76 first-line group
77 graft
78 group
79 host disease
80 incidence
81 individual patients
82 infusion
83 knowledge
84 leukemia
85 limited knowledge
86 lines
87 lymphocyte infusion
88 median
89 median duration
90 molecular relapse
91 months
92 multicenter analysis
93 myelodysplastic syndrome
94 myeloid leukemia
95 overall response rate
96 partial remission
97 patients
98 rate
99 relapse
100 relapsing
101 remission
102 response rate
103 results
104 retrospective multicenter analysis
105 salvage therapy
106 second choice
107 second-line treatment
108 stem cell transplantation
109 study group
110 syndrome
111 therapy
112 transplant centers
113 transplantation
114 treatment
115 schema:name Treatment of relapsed AML and MDS after allogeneic stem cell transplantation with decitabine and DLI—a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group
116 schema:pagination 335-342
117 schema:productId N8727a37899744f88a994731ff915bef9
118 N876771d702b54c20be31bc571b86d410
119 Nbdfa9bdc74bd4c18b3fe452b3a807502
120 schema:sameAs https://app.dimensions.ai/details/publication/pub.1092764909
121 https://doi.org/10.1007/s00277-017-3185-5
122 schema:sdDatePublished 2022-08-04T17:05
123 schema:sdLicense https://scigraph.springernature.com/explorer/license/
124 schema:sdPublisher N14b73bc43070445cb97646ec45fb7474
125 schema:url https://doi.org/10.1007/s00277-017-3185-5
126 sgo:license sg:explorer/license/
127 sgo:sdDataset articles
128 rdf:type schema:ScholarlyArticle
129 N0f7981716dc8407b87519864fe107a47 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Female
131 rdf:type schema:DefinedTerm
132 N14b73bc43070445cb97646ec45fb7474 schema:name Springer Nature - SN SciGraph project
133 rdf:type schema:Organization
134 N1572c682fdcb439084a0aa5bc0a11655 rdf:first sg:person.016431005447.39
135 rdf:rest Nd7f58c45662642c09ba3751a1aa71cf4
136 N2e048e5cfa324c5390acb2a3516dde47 rdf:first sg:person.0660354231.27
137 rdf:rest N1572c682fdcb439084a0aa5bc0a11655
138 N3b33f19a81f6453eb18a3425c7ef7207 rdf:first sg:person.01271136615.68
139 rdf:rest N62b347d3f2dc46488b3141507a8b9e43
140 N4f6649d94f5445d4a0c8364f5275b361 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Graft vs Host Disease
142 rdf:type schema:DefinedTerm
143 N599f6b35a9d14ca29ef933af7e0f1643 rdf:first sg:person.01036310055.41
144 rdf:rest N68cc865a4a81494092255e95ae6c6ad8
145 N617f8b0c582842daa045e97e144f1153 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
146 schema:name Remission Induction
147 rdf:type schema:DefinedTerm
148 N62b347d3f2dc46488b3141507a8b9e43 rdf:first sg:person.014702750321.08
149 rdf:rest Nccd74195a318439183f76b7fe1baa30c
150 N660f3f1c24434b53aedc9836e37281bf rdf:first sg:person.0766505315.56
151 rdf:rest Nd8af729d106a4ab19ea8c5e0a3e0d134
152 N679dc90214034ca88f35b925f8bf5a7b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Decitabine
154 rdf:type schema:DefinedTerm
155 N68cc865a4a81494092255e95ae6c6ad8 rdf:first sg:person.01164073234.53
156 rdf:rest rdf:nil
157 N6e1d7328a75f4f959ba359420d518e6d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
158 schema:name Recurrence
159 rdf:type schema:DefinedTerm
160 N778e6b63cbdd499d98bd2be7d8419237 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 schema:name Hematopoietic Stem Cell Transplantation
162 rdf:type schema:DefinedTerm
163 N7d64c1ba510c40bd80d82c0e4a66cd18 rdf:first sg:person.01150516001.45
164 rdf:rest N660f3f1c24434b53aedc9836e37281bf
165 N8093015258c549d6903167d972f76a85 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
166 schema:name Aged
167 rdf:type schema:DefinedTerm
168 N828b9825985a4f068d7bb7f456fcbcfc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
169 schema:name Humans
170 rdf:type schema:DefinedTerm
171 N8727a37899744f88a994731ff915bef9 schema:name dimensions_id
172 schema:value pub.1092764909
173 rdf:type schema:PropertyValue
174 N876771d702b54c20be31bc571b86d410 schema:name doi
175 schema:value 10.1007/s00277-017-3185-5
176 rdf:type schema:PropertyValue
177 N8b97b9e1874c4322bc475c7ac4dfe0f5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
178 schema:name Adult
179 rdf:type schema:DefinedTerm
180 Naad72d3432c546d59c207e9fa0d112ca schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
181 schema:name Treatment Outcome
182 rdf:type schema:DefinedTerm
183 Naaf8350563bb43ca87f3301cbb79b061 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
184 schema:name Leukemia, Myeloid, Acute
185 rdf:type schema:DefinedTerm
186 Nab7f64703be141a581bb5f31d7b50b69 schema:volumeNumber 97
187 rdf:type schema:PublicationVolume
188 Nb1737913499c4b32ab05d24b948e3b52 schema:issueNumber 2
189 rdf:type schema:PublicationIssue
190 Nb309da5affc440378f21cfc550396691 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
191 schema:name Transplantation, Homologous
192 rdf:type schema:DefinedTerm
193 Nbb809e4e496746eeb124cbda2cc1ff6d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
194 schema:name Male
195 rdf:type schema:DefinedTerm
196 Nbdfa9bdc74bd4c18b3fe452b3a807502 schema:name pubmed_id
197 schema:value 29151133
198 rdf:type schema:PropertyValue
199 Nbeafec1aac20491bad253e5fc0cabfdf rdf:first sg:person.01367010764.53
200 rdf:rest N7d64c1ba510c40bd80d82c0e4a66cd18
201 Nc45eda7089dd40179139d331338c8377 rdf:first sg:person.01362464041.20
202 rdf:rest N599f6b35a9d14ca29ef933af7e0f1643
203 Nc605934229a9432ebea2a9feb33b5917 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
204 schema:name Retrospective Studies
205 rdf:type schema:DefinedTerm
206 Ncae05d567e5246738d1f0c655c67f9d6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
207 schema:name Salvage Therapy
208 rdf:type schema:DefinedTerm
209 Nccd74195a318439183f76b7fe1baa30c rdf:first sg:person.01121306556.02
210 rdf:rest Ne16d36b807f643d6bc6baa10df30cf0e
211 Ncef7ef0d28b8473d876a1c5136bfb751 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
212 schema:name Survival Analysis
213 rdf:type schema:DefinedTerm
214 Nd54542c355f849a0b95c0f1458a2feb5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
215 schema:name Myelodysplastic Syndromes
216 rdf:type schema:DefinedTerm
217 Nd7f58c45662642c09ba3751a1aa71cf4 rdf:first sg:person.01007205467.33
218 rdf:rest Nea28518fcf5f40a6b8e41380a3cc98d8
219 Nd8af729d106a4ab19ea8c5e0a3e0d134 rdf:first sg:person.01127414674.14
220 rdf:rest Nc45eda7089dd40179139d331338c8377
221 Ndd8c351aab8e4d488bec8ffd518271fe schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
222 schema:name Lymphocyte Transfusion
223 rdf:type schema:DefinedTerm
224 Ndffcccf166464f2ea0bcf7bee6ba718d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
225 schema:name Azacitidine
226 rdf:type schema:DefinedTerm
227 Ne16d36b807f643d6bc6baa10df30cf0e rdf:first sg:person.0670313557.25
228 rdf:rest N2e048e5cfa324c5390acb2a3516dde47
229 Ne98a1478f6b44cd58fcf22c2aae235f0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
230 schema:name Middle Aged
231 rdf:type schema:DefinedTerm
232 Nea28518fcf5f40a6b8e41380a3cc98d8 rdf:first sg:person.01200517504.74
233 rdf:rest Nbeafec1aac20491bad253e5fc0cabfdf
234 Nf9ad27ec409f43e286cc5086aa96be20 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
235 schema:name Antimetabolites, Antineoplastic
236 rdf:type schema:DefinedTerm
237 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
238 schema:name Medical and Health Sciences
239 rdf:type schema:DefinedTerm
240 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
241 schema:name Cardiorespiratory Medicine and Haematology
242 rdf:type schema:DefinedTerm
243 sg:journal.1358129 schema:issn 0939-5555
244 1432-0584
245 schema:name Annals of Hematology
246 schema:publisher Springer Nature
247 rdf:type schema:Periodical
248 sg:person.01007205467.33 schema:affiliation grid-institutes:grid.411778.c
249 schema:familyName Klein
250 schema:givenName Stefan
251 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01007205467.33
252 rdf:type schema:Person
253 sg:person.01036310055.41 schema:affiliation grid-institutes:grid.412282.f
254 schema:familyName Bornhäuser
255 schema:givenName Martin
256 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01036310055.41
257 rdf:type schema:Person
258 sg:person.01121306556.02 schema:affiliation grid-institutes:grid.5603.0
259 schema:familyName Krüger
260 schema:givenName William
261 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01121306556.02
262 rdf:type schema:Person
263 sg:person.01127414674.14 schema:affiliation grid-institutes:None
264 schema:familyName Haas
265 schema:givenName Rainer
266 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01127414674.14
267 rdf:type schema:Person
268 sg:person.01150516001.45 schema:affiliation grid-institutes:None
269 schema:familyName Kondakci
270 schema:givenName Mustafa
271 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01150516001.45
272 rdf:type schema:Person
273 sg:person.01164073234.53 schema:affiliation grid-institutes:None
274 schema:familyName Kobbe
275 schema:givenName Guido
276 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01164073234.53
277 rdf:type schema:Person
278 sg:person.01200517504.74 schema:affiliation grid-institutes:None
279 schema:familyName Hopfer
280 schema:givenName Olaf
281 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01200517504.74
282 rdf:type schema:Person
283 sg:person.01271136615.68 schema:affiliation grid-institutes:None
284 schema:familyName Schroeder
285 schema:givenName Thomas
286 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01271136615.68
287 rdf:type schema:Person
288 sg:person.01362464041.20 schema:affiliation grid-institutes:None
289 schema:familyName Germing
290 schema:givenName Ulrich
291 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01362464041.20
292 rdf:type schema:Person
293 sg:person.01367010764.53 schema:affiliation grid-institutes:None
294 schema:familyName Nachtkamp
295 schema:givenName Kathrin
296 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01367010764.53
297 rdf:type schema:Person
298 sg:person.014702750321.08 schema:affiliation grid-institutes:None
299 schema:familyName Rautenberg
300 schema:givenName Christina
301 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014702750321.08
302 rdf:type schema:Person
303 sg:person.016431005447.39 schema:affiliation grid-institutes:grid.411088.4
304 schema:familyName Steinmann
305 schema:givenName Juliane
306 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016431005447.39
307 rdf:type schema:Person
308 sg:person.0660354231.27 schema:affiliation grid-institutes:grid.411088.4
309 schema:familyName Bug
310 schema:givenName Gesine
311 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0660354231.27
312 rdf:type schema:Person
313 sg:person.0670313557.25 schema:affiliation grid-institutes:grid.412282.f
314 schema:familyName Platzbecker
315 schema:givenName Uwe
316 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0670313557.25
317 rdf:type schema:Person
318 sg:person.0766505315.56 schema:affiliation grid-institutes:None
319 schema:familyName Geyh
320 schema:givenName Stefanie
321 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0766505315.56
322 rdf:type schema:Person
323 sg:pub.10.1007/s00277-012-1607-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1021337269
324 https://doi.org/10.1007/s00277-012-1607-y
325 rdf:type schema:CreativeWork
326 sg:pub.10.1038/bmt.2009.222 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042146563
327 https://doi.org/10.1038/bmt.2009.222
328 rdf:type schema:CreativeWork
329 sg:pub.10.1038/bmt.2009.266 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026051000
330 https://doi.org/10.1038/bmt.2009.266
331 rdf:type schema:CreativeWork
332 sg:pub.10.1038/bmt.2013.233 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048090912
333 https://doi.org/10.1038/bmt.2013.233
334 rdf:type schema:CreativeWork
335 sg:pub.10.1038/bmt.2015.10 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034490318
336 https://doi.org/10.1038/bmt.2015.10
337 rdf:type schema:CreativeWork
338 sg:pub.10.1038/leu.2011.234 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037902470
339 https://doi.org/10.1038/leu.2011.234
340 rdf:type schema:CreativeWork
341 sg:pub.10.1038/leu.2013.64 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051101519
342 https://doi.org/10.1038/leu.2013.64
343 rdf:type schema:CreativeWork
344 sg:pub.10.1038/leu.2013.7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019069739
345 https://doi.org/10.1038/leu.2013.7
346 rdf:type schema:CreativeWork
347 grid-institutes:None schema:alternateName Department of Hematology, Oncology and Clinical Immunology, Medical Faculty, University of Duesseldorf, Moorenstr. 5, 40225, Düsseldorf, Germany
348 Klinikum Frankfurt (Oder) GmbH, Med. Clinic I, Frankfurt (Oder), Frankfurt, Germany
349 schema:name Department of Hematology, Oncology and Clinical Immunology, Medical Faculty, University of Duesseldorf, Moorenstr. 5, 40225, Düsseldorf, Germany
350 Klinikum Frankfurt (Oder) GmbH, Med. Clinic I, Frankfurt (Oder), Frankfurt, Germany
351 rdf:type schema:Organization
352 grid-institutes:grid.411088.4 schema:alternateName Department of Medicine II, University Hospital Frankfurt, Frankfurt am Main, Germany
353 schema:name Department of Medicine II, University Hospital Frankfurt, Frankfurt am Main, Germany
354 rdf:type schema:Organization
355 grid-institutes:grid.411778.c schema:alternateName Med. Clinic III, University Medicine Mannheim, Mannheim, Germany
356 schema:name Med. Clinic III, University Medicine Mannheim, Mannheim, Germany
357 rdf:type schema:Organization
358 grid-institutes:grid.412282.f schema:alternateName Medical Clinic and Policlinic I, University Hospital Carl Gustav Carus, Dresden, Germany
359 schema:name Medical Clinic and Policlinic I, University Hospital Carl Gustav Carus, Dresden, Germany
360 rdf:type schema:Organization
361 grid-institutes:grid.5603.0 schema:alternateName Clinic and Policlinic for Internal Medicine C, Hematology and Oncology, University of Greifswald, Greifswald, Germany
362 schema:name Clinic and Policlinic for Internal Medicine C, Hematology and Oncology, University of Greifswald, Greifswald, Germany
363 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...